Microbiological diagnosis of coincident mycobacterial infection in cystic fibrosis

Diseases caused by mycobacteria, leprosy and tuberculosis, are widely known for many centuries. However, interest in mycobacteriosis, as an infectious disease of human organs caused by other mycobacteria, was only apparent from the late 50s of the 20th century. Over the years of observation, the number of cases of mycobacteriosis in various regions of the world has increased significantly, including in patients with cystic fibrosis. A key sign of comorbidity in cystic fibrosis is a chronic microbial infection that determines the severity of the course and the prognosis of the disease. In order to identify and identify mycobacteria isolated from patients with cystic fibrosis from 2011 to 2018, sputum was examined from 160 patients with cystic fibrosis and suspected mycobacterial infection. Mycobacteria were secreted in 17 (10.6%) patients with cystic fibrosis, of which non-tuberculous mycobacteria predominated. Thirteen patients were infected with M. abscessus (76.4%), two with M.avium (11.7%), one with M.xenopi (5.8%), one with M. tuberculosis (5.8%). Determination of drug sensitivity of mycobacteria showed that the culture of M.tuberculosis was sensitive to all antituberculosis drugs, and strains of nontuberculous mycobacteria had a different spectrum of drug susceptibility to drugs used for the therapy of mycobacteriosis. Identification of infectious agents will help ensure the timely initiation of adequate treatment, proper monitoring and prevention of the spread of non-tuberculosis mycobacteria among patients with cystic fibrosis .

Муковисцидоз, микобактерии, нетуберкулезные микобактерии, идентификация, лекарственная чувствительность, Сystic fibrosis, mycobacteria, nontuberculosis mycobacteria, identification, drug susceptibility

1. Timpe A, Runyon E.H. The relationship of atypical acid-fast bacteria to human disease; a preliminary report. J Lab Clin Med. 1954; 8; 44(2):202-9.

2. Falkinham J.O. Epidemiology of Infection by Nontuberculous Mycobacteria Clinical microbiology reviews. 1996, 4: 177-215. Vol. 9, No. 2.

3. Mazza-Stalder J., Jaton-Ogay K., Nicod L. Non tuberculous mycobacteria pulmonary disease: what's new? Service de pneumologie, Institut de microbiologie CHUV, 1011 Lausanne. Jesica // Rev Med Suisse. -2009.- Vol. 5.- № 226.-Р. 2344-6, 2348-50.

4. Оттен Т.Ф., Васильев А.В. Микобактериоз. СПб.: Медицинская пресса; 2005.

5. Литвинов В.И., Дорожкова И.Р., Макарова М.В., Краснова М.А., Фрейман Г.Е. Выделение и идентификация нетуберкулезных микобактерий. Вестник РАМН. 2010; 3:11.

6. Viviani L, Harrison M. J., Zolin A, Haworth C. S., R. Floto A. Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF). Journal of Cystic Fibrosis. 2016; 15: 619-623.

7. Cutting G.R. Genotype defect: its effect on cellular function and phenotypic expression. Am. J. Respir. Crit. Care Med. 1994; 15: 356-363

8. McKone E.F., Jackson A., Zolin A., Boeck K. De, Rens J. van, Ariti C., Keogh R., Naehrlich L. Genetic epidemiology of CFTR nonsense mutations across Europe Journal of Cystic Fibrosis. 2017; 16(1): 47.

9. Кондратьева Е.И., Воронкова А.Ю., Бобровничий В.И., Шерман В.Д., Жекайте Е.К., Никонова В.С., и др. Клинико-генетическая и микробиологическая характеристика больных муковисцидозом, проживающих в Московском регионе и Республике Беларусь. Пульмонология. 2018;28(3):296-306.

10. Garczewska B,Jarzynka S,Kus J,Skorupa W,Augustynowicz-Kopec E. Fungal infection of cystic fibrosis patients - single center experience. Pneumonol Alergol Pol. 2016;84(3):151-9.

11. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardia, and other aerobic actynomycetes;approved Standard, M24-A2. Wayne, PA: CLSI. 2011:76

12. Binder A.M, Adjemian J, Olivier K.N, Prevots D.R. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med. 2013; 188(7):807-12.

13. Смирнова Т.Г., Андреевская С.Н., Ларионова Е.Е., Андриевская И.Ю., Устинова В.В., Черноусова Л.Н. Мониторинг видового разнообразия нетуберкулезных микобактерий в ряде областей РФ с использованием ДНК-стрипов GenoType Mycobacterium CM/ AS (Hain Lifescience, Германия). Туберкулёз и болезни лёгких. 2017; 95(5): 54-59.

14. Manika K, Giouleka P, Zarogoulidis K, Kioumis I. Multidrug-resistant tuberculosis in an adult with cystic fibrosis. Respiration. 2013;85(4):350-3.

15. Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis. 2008; 14(3):378-84.